Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance.

MLA

Meiyi Zhou, et al. “Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance.” Diabetes, vol. 68, no. 9, Sept. 2019, pp. 1730–46. EBSCOhost, https://doi.org/10.2337/db18-0927.

APA

Meiyi Zhou, Jing Shao, Cheng-Yang Wu, Le Shu, Weibing Dong, Yunxia Liu, Mengping Chen, Wynn, R. M., Jiqiu Wang, Ji Wang, Wen-Jun Gui, Xiangbing Qi, Lusis, A. J., Zhaoping Li, Weiqing Wang, Guang Ning, Xia Yang, Chuang, D. T., Yibin Wang, & Haipeng Sun. (2019). Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance. Diabetes, 68(9), 1730–1746. https://doi.org/10.2337/db18-0927

Chicago

Meiyi Zhou, Jing Shao, Cheng-Yang Wu, Le Shu, Weibing Dong, Yunxia Liu, Mengping Chen, et al. 2019. “Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance.” Diabetes 68 (9): 1730–46. doi:10.2337/db18-0927.